MIXTURE of human expertise and deep learning—developing an explainable model for predicting pathological diagnosis and survival in patients with interstitial lung disease
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Interstitial pneumonia is a heterogeneous disease with a progressive course and poor prognosis, at times even worse than those in the main cancer types. Histopathological examination is crucial for its diagnosis and estimation of prognosis. However, the evaluation strongly depends on the experience of pathologists, and the reproducibility of diagnosis is low. Herein, we propose MIXTURE (huMan-In-the-loop eXplainable artificial intelligence Through the Use of REcurrent training), an original method to develop deep learning models for extracting pathologically significant findings based on an expert pathologist's perspective with a small annotation effort. The procedure of MIXTURE consists of three steps as follows. First, we created feature extractors for tiles from whole slide images using self-supervised learning. The similar looking tiles were clustered based on the output features and then pathologists integrated the pathologically synonymous clusters. Using the integrated clusters as labeled data, deep learning models to classify the tiles into pathological findings were created by transfer-learning the feature extractors. We developed three models for different magnifications. Using these extracted findings, our model was able to predict the diagnosis of usual interstitial pneumonia, a finding suggestive of progressive disease, with high accuracy (AUC 0.90 in validation set and AUC 0.86 in test set). This high accuracy could not be achieved without the integration of findings by pathologists. The patients predicted as UIP had poorer prognosis (5-year overall survival [OS]: 55.4%) than those predicted as non-UIP (OS: 95.2%). The Cox proportional hazards model for each microscopic finding and prognosis pointed out dense fibrosis, fibroblastic foci, elastosis, and lymphocyte aggregation as independent risk factors. We suggest that MIXTURE may serve as a model approach to different diseases evaluated by medical imaging, including pathology and radiology, and be the prototype for explainable artificial intelligence that can collaborate with humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
Raghu, G., Remy-Jardin, M., Myers, J. L., Richeldi, L., Ryerson, C. J., Lederer, D. J., Behr, J., Cottin, V., Danoff, S. K., Morell, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1255st · Cited by 4,103
Self-citationA phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Coudray, N., Ocampo, P. S., Sakellaropoulos, T., Narula, N., Snuderl, M., Fenyö, D., Moreira, A. L., Razavian, N., & Tsirigos, A. (2018) · Nature Medicine · doi:10.1038/s41591-018-0177-5 · Cited by 2,930 · cited 1×
“The proposed approach does not adopt an end-to-end learning structure, which is common in state-of-the-art research[22, 43].”
OpenSlide: A vendor-neutral software foundation for digital pathology
Goode, A., Gilbert, B., Harkes, J., Jukic, D., & Satyanarayanan, M. (2013) · Journal of Pathology Informatics · doi:10.4103/2153-3539.119005 · Cited by 546
Deep learning-based classification of mesothelioma improves prediction of patient outcome
Courtiol, P., Maussion, C., Moarii, M., Pronier, E., Pilcer, S., Sefta, M., Manceron, P., Toldo, S., Zaslavskiy, M., Le Stang, N., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0583-3 · Cited by 544 · cited 1×
“eas that contribute to the output[22, 44], it is still necessary to reinterpret the output from an expert perspective.”
Number of pathologists in Germany: comparison with European countries, USA, and Canada
Märkl, B., Füzesi, L., Huss, R., Bauer, S., & Schaller, T. (2021) · Virchows Archiv · doi:10.1007/s00428-020-02894-6 · Cited by 115
Cited by
Artificial intelligence in histopathology: enhancing cancer research and clinical oncology
Shmatko, A., Ghaffari Laleh, N., Gerstung, M., & Kather, J. N. (2022) · Nature Cancer · doi:10.1038/s43018-022-00436-4 · Cited by 446
“Variations of these commonly used approaches include the introduction of an explicit ‘normal tissue’ class in the mutational classifier 75 or clustering of tiles with subsequent expert-based rating of clusters 116 .”
MethodMcGenity, C., Clarke, E. L., Jennings, C., Matthews, G., Cartlidge, C., Freduah-Agyemang, H., Stocken, D. D., & Treanor, D. (2024) · npj Digital Medicine · doi:10.1038/s41746-024-01106-8 · Cited by 290
Savin, I. A., Zenkova, M. A., & Sen’kova, A. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314959 · Cited by 279
ŞAHiN, E., Arslan, N. N., & Özdemir, D. (2025) · Neural Computing and Applications · doi:10.1007/s00521-024-10437-2 · Cited by 278
CDSS for Early Recognition of Respiratory Diseases Based on AI Techniques: A Systematic Review
Ali, S. W., Asif, M., Zia, M. Y. I., Rashid, M., Syed, S. A., & Nava, E. (2023) · Wireless Personal Communications · doi:10.1007/s11277-023-10432-1 · Cited by 13
““Bagging” is pronounced as “Bootstrap and Aggregation” [54-59].”
Metadata
- Authors
- Uegami, W., Bychkov, A., Ozasa, M., Uehara, K., Kataoka, K., Johkoh, T., Kondoh, Y., Sakanashi, H., & Fukuoka, J.
- Venue
- Modern Pathology
- Publisher
- Elsevier BV
- Published
- 2022-08
- Volume
- 35
- Issue
- 8
- Pages
- 1083-1091
- ISSN
- 0893-3952 (ISSN-L)
- OpenAlex
- W4214670085
- Cited by
- 54
- References
- 7
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MIXTURE of human expertise and deep learning—developing an explainable model for predicting pathological diagnosis and survival in patients with interstitial lung disease. https://app.cochat.ai/papers/10.1038/s41379-022-01025-7
- The paper
- Uegami, W., Bychkov, A., Ozasa, M., Uehara, K., Kataoka, K., Johkoh, T., Kondoh, Y., Sakanashi, H., & Fukuoka, J. (2022). MIXTURE of human expertise and deep learning—developing an explainable model for predicting pathological diagnosis and survival in patients with interstitial lung disease. Modern Pathology. https://doi.org/10.1038/s41379-022-01025-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.